AU3469100A - Sustained release formulation with reduced moisture sensitivity - Google Patents

Sustained release formulation with reduced moisture sensitivity

Info

Publication number
AU3469100A
AU3469100A AU34691/00A AU3469100A AU3469100A AU 3469100 A AU3469100 A AU 3469100A AU 34691/00 A AU34691/00 A AU 34691/00A AU 3469100 A AU3469100 A AU 3469100A AU 3469100 A AU3469100 A AU 3469100A
Authority
AU
Australia
Prior art keywords
sustained release
release formulation
reduced moisture
moisture sensitivity
sensitivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34691/00A
Inventor
Shubha Chungi
Theodore L. Iorio
Kangwen Lin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Copley Pharmaceuticals Inc
Original Assignee
Copley Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US22579599A priority Critical
Priority to US09225795 priority
Application filed by Copley Pharmaceuticals Inc filed Critical Copley Pharmaceuticals Inc
Priority to PCT/US2000/000088 priority patent/WO2000040205A2/en
Publication of AU3469100A publication Critical patent/AU3469100A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
AU34691/00A 1999-01-05 2000-01-04 Sustained release formulation with reduced moisture sensitivity Abandoned AU3469100A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US22579599A true 1999-01-05 1999-01-05
US09225795 1999-01-05
PCT/US2000/000088 WO2000040205A2 (en) 1999-01-05 2000-01-04 Sustained release formulation with reduced moisture sensitivity

Publications (1)

Publication Number Publication Date
AU3469100A true AU3469100A (en) 2000-07-24

Family

ID=22846274

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34691/00A Abandoned AU3469100A (en) 1999-01-05 2000-01-04 Sustained release formulation with reduced moisture sensitivity

Country Status (2)

Country Link
AU (1) AU3469100A (en)
WO (1) WO2000040205A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20050100608A1 (en) * 2003-02-21 2005-05-12 Watson Pharmaceuticals, Inc. Testosterone oral dosage formulations and associated methods
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032049A1 (en) * 2004-07-01 2006-01-19 Grünenthal GmbH Abuse-proofed, oral dosage form
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Unbreakable dosage forms with delayed release
FR2887455B1 (en) * 2005-06-28 2007-08-10 Sanofi Aventis Sa Formulation of sustained release of active drugs
TWI454288B (en) 2008-01-25 2014-10-01 Gruenenthal Chemie Pharmaceutical dosage form
RU2508092C2 (en) 2008-05-09 2014-02-27 Грюненталь Гмбх Method for preparing solid dosage form, particularly tablet for pharmaceutical application and method for preparing solid dosage form precursor, particularly tablet
CA2767888C (en) 2009-07-22 2017-09-12 Gruenenthal Gmbh Tamper-resistant dosage form for oxidation-sensitive opioids
PE10672012A1 (en) 2009-07-22 2012-09-05 Gruenenthal Chemie Form of controlled release dosage extruded by hot melt
JP5933553B2 (en) 2010-09-02 2016-06-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Abuse-resistant dosage form comprising an anionic polymer
KR20130097202A (en) 2010-09-02 2013-09-02 그뤼넨탈 게엠베하 Tamper resistant dosage form comprising inorganic salt
HUE034711T2 (en) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
DK2838512T3 (en) 2012-04-18 2018-11-19 Gruenenthal Gmbh Tamper-proof and dose dumping secured pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JP6445537B2 (en) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Tamper-resistant dosage forms containing one or more particles
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
JP2017518980A (en) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Containing tapentadol, modified prevent immediate release capsule formulation
MX2016015417A (en) 2014-05-26 2017-02-22 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping.
KR20170139158A (en) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 Immediate release and solvent extraction inhibition modulated dosage form

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
DE4329794C2 (en) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadol salt-containing drugs with delayed release

Also Published As

Publication number Publication date
WO2000040205A2 (en) 2000-07-13
WO2000040205A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
AU771341C (en) Soluble fertilizer formulation
EP1369049B8 (en) Shoe
AU780513C (en) Sensitive substance encapsulation
AU2743200A (en) Holter-type monitor system comprising an analyte sensor
AU8033300A (en) Low-cost accelerometer
AU4128000A (en) Implantable sensor
AU3189900A (en) Solid state thermoelectric device
AU6984100A (en) Silicon-based sensor system
AU3243300A (en) Multiparticulate formulation
AU6381300A (en) Opioid sustained-released formulation
AU7641300A (en) Release system
AU6791300A (en) Arrhythmia display
AU5623100A (en) Characteristic monitor system for use with analyte sensor
AU6008400A (en) Current sensor
AU6114300A (en) Colorimeter
AU5406600A (en) Microcapsules - i
AU6265000A (en) Microcapsules - iii
AU5977300A (en) Microcapsules - ii
AU1173201A (en) Skin-gripper
AU5805700A (en) Glucoamylase variant
AU2184401A (en) Low-permeability connecting device
AU7809600A (en) Tape measure
AU3990797A (en) Sustained release formulation
AU5842000A (en) Interventive-diagnostic device
EP1072453A3 (en) Refrigeration-cycle device

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase